Papers
2
Total Citations
38
H-Index
2
About
Dr. Liping Song is a pioneering researcher at the intersection of advanced sensor technology and biomedical vaccine development. Her work spans two transformative fields: intelligent tactile sensing systems and high-throughput virology assays. In her landmark 2023 study, Dr. Song developed a machine learning-coupled tactile recognition system based on a cross-striped nanocarbon piezoresistive sensor array, achieving high spatiotemporal resolution for robotic and wearable applications. This highly cited work (34 citations) has significantly advanced the field of electronic skin and human-machine interaction. Concurrently, Dr. Song addresses critical global health challenges through her 2024 development of a fully automated high-throughput immuno-µPlaque assay for live-attenuated tetravalent dengue vaccine development. With dengue fever threatening half the world’s population, her automated platform streamlines the evaluation of leading vaccine candidates, offering a scalable solution to accelerate vaccine production and quality control. By bridging cutting-edge materials science with pressing biomedical needs, Dr. Song’s dual-impact research demonstrates remarkable versatility—enhancing both robotic perception and global pandemic preparedness through innovative, high-precision methodologies.
Research Focus
Key Achievements
Top Papers
- 1
- 2